Search results
Story from Associated Retina Consultants: Local group helps macular degeneration patients cope with...
The Arizona Republic· 13 hours agoAccording to the Centers for Disease Control and Prevention (CDC), nearly 20 million Americans over...
Dear Doctor: Can I use over-the-counter eye drops while on medications for macular degeneration?
OregonLive.com· 1 day agoROACH: I am a healthy 67-year-old female being treated with Eylea for wet age-related macular degeneration (AMD). Is it safe to use over-the-counter ...
Breakthrough Study Reveals Somavedic Device's Potential Impact on Wet AMD Patients
WTNH-TV New Haven· 3 days agoThe study enrolled patients with newly diagnosed wet AMD and active choroidal neovascularization (CNV), where anti-VEGF therapy was indicated.
Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks
Pharmaceutical Technology via Yahoo Finance· 8 hours agoHowever, Roche’s market capitalisation fell by 12.4%, largely attributed to the decline in demand...
Health Care Roundup: Market Talk
The Wall Street Journal· 4 days agoMoreover, its planned launch of aflibercept—for patients living with wet macular degeneration—could be a potentially significant biosimilar ...
2 Small-Cap Growth Stocks With Room to Run
Motley Fool via Yahoo Finance· 2 days agoCurrently, Wall Street analysts believe the company's shares could be undervalued by as much as 210%. The reason? Ocular is developing a novel therapy...
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC...
Morningstar· 4 days agoPreclinical data from the next generation eyedrop platform to be unveiled for the first time at ARVO 2024DAEJEON, South Korea, April 22, 2024 /PRNewswire/ -- PharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public
Local women with low vision gather to share experiences, advances in tech
telegraphherald.com· 6 days agoGathered around a long table in the back of Caroline’s Restaurant in Dubuque, a group of women...
Cwm LLC Sells 256 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 15 hours agoCwm LLC lowered its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 9.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange ...
Ocugen (NASDAQ:OCGN) Given New $5.00 Price Target at Chardan Capital
ETF DAILY NEWS· 5 days agoOcugen (NASDAQ:OCGN – Get Free Report) had its price objective increased by stock analysts at Chardan Capital from $4.00 to $5.00 in a research report issued on Monday, Benzinga reports. Chardan ...
